Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Nikolaos Giannelos, PhD

GSK, Belgium

Disclosure(s): GSK: Employee, Stocks/Bonds (Private Company)

Poster(s):

(P-17) Worldwide Impact of Increased Recombinant Zoster Vaccine Coverage on the Burden of Herpes Zoster, based on 11-year Clinical Trial Follow-up Data, in Adults Aged ≥50 Years

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT